CORDY

News

  1. Top
  2. Business area
  3. News
2007/05/15
Research progress regarding the "Vascular Injury marker Pentraxin 3(PTX3)" will be presented at Digestive Disease Week 2007
2007/04/25
Research progress regarding the "Vascular Injury marker Pentraxin 3(PTX3)" will be presented at The 51st Annual General Assembly and Scientific Meeting of Japan College of Rheumatology
2007/04/21
Development of Cystatin SN as a new diagnostic marker for colon cancer Reported at The 93rd Annual Meeting of the Japanese Society of Gastroenterology
2007/03/25
Research progress regarding the " Vascular Injury marker Pentraxin 3(PTX3)" will be presented at The American college of cardiology held on March 24-27th, 2007 in New Orleans.
2007/03/08
Research progress regarding the "Vascular Injury marker Pentraxin 3(PTX3)" will be presented at The 71st Annual Scientific Meeting of the Japanese Circulation Society held on March 15-17th, 2007 in Kobe.
2007/03/02
Our Collaboration Research results regarding "The Vascular Injury Marker PTX3" and "Research in Nuclear Hormone Receptors" will be presented at the 96th Annual Pathology Meeting.
2007/01/31
Pentraxin 3 levels indicate unstable angina [Reuters - Therapeutics Daily]
2006/11/11
Our scientific article using Perseus Proteomics human ELISA system "Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris" was just published.
2006/10/12
Perseus Proteomics and Chugai Pharmaceutical reach purchase and sales agreement on glypican-3 therapeutic antibody.